Thromboembolism after coronavirus disease 2019 vaccination in atrial fibrillation/flutter: a self-controlled case series study.
You-Jung ChoiJae-Hyun LimSungho BeaJieun LeeJah Yeon ChoiSeung Young RhoDae-In LeeJin Oh NaHyung Kwan KimPublished in: European heart journal (2024)
In patients with AF/AFL, COVID-19 vaccination was generally not associated with an increased risk of thrombo-embolic events. However, careful individual risk assessment is required when advising vaccination for those not on oral anticoagulant, as these patients exhibited an increased risk of thrombo-embolic events post-vaccination.
Keyphrases
- atrial fibrillation
- coronavirus disease
- risk assessment
- end stage renal disease
- oral anticoagulants
- newly diagnosed
- sars cov
- ejection fraction
- heart failure
- direct oral anticoagulants
- left atrial appendage
- venous thromboembolism
- prognostic factors
- peritoneal dialysis
- respiratory syndrome coronavirus
- human health
- acute coronary syndrome